Xuelei Wang

Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle.

Xiaowei Wang, Jie Ma, Guimin Xia, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Structure-activity relationship and biological evaluation of berberine derivatives as PCSK9 down-regulating agents.

Li Wang, Wei Wei, Yanxiang Wang, 2021, Bioorganic chemistry.

A small-molecule inhibitor of PCSK9 transcription ameliorates atherosclerosis through the modulation of FoxO1/3 and HNF1α

Yu Du, Chunyan Su, Li Wang, 2020, EBioMedicine.

Novel 5-Fluorouracil Carbonate-Loaded Liposome: Preparation, In Vitro, and In Vivo Evaluation as an Antitumor Agent.

Xiaowei Wang, Guimin Xia, Dan Wang, 2022, Molecular pharmaceutics.

Antisense microRNA185 loaded liposome for efficient inhibition of the hepatic endogenous microRNA185 level.

Jie Ma, B. Hong, Guimin Xia, 2021, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome

Xiaowei Wang, W. Yuan, Wu-li Zhao, 2020, Pharmaceutical development and technology.

MicroRNA-185 modulates CYP7A1 mediated cholesterol-bile acid metabolism through post-transcriptional and post-translational regulation of FoxO1.

Yu Du, Li Wang, Xuelei Wang, 2022, Atherosclerosis.

The Endocytic Mechanism and Cytotoxicity of Boron-containing Vesicles.

Qiang Zhang, Guimin Xia, Dan Wang, 2020, Chemical and pharmaceutical bulletin.

Strategies to Promote the Journey of Nanoparticles Against Biofilm-Associated Infections.

Xiaowei Wang, Guimin Xia, Xuelei Wang, 2024, Small.